Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Deibert

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cancer|January 25, 2022
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter studyEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Neurosurgery|October 18, 2022
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 PatientsEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Journal of Neurosurgery|September 17, 2022
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patientsEric J Lehrer, Manmeet S Ahluwalia, Jason Gurewitz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2023
Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain MetastasesEric J Lehrer, Roman O Kowalchuk, Jason Gurewitz, et al.
Journal of Neuro-Oncology|October 27, 2023
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patientsEric J Lehrer, Atulya A Khosla, Ahmad Ozair, et al.
Journal of Neurosurgery|October 28, 2022
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a multi-institutional studyStylianos Pikis, Georgios Mantziaris, Rithika Kormath Anand, et al.
Acta Neurochirurgica|December 21, 2022
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in patients ≥ 65 years old: a multi-institutional retrospective studyChloe Dumot, Stylianos Pikis, Georgios Mantziaris, et al.
Journal of Neuro-Oncology|September 27, 2022
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional studyChloe Dumot, Stylianos Pikis, Georgios Mantziaris, et al.
Journal of the National Cancer Institute|May 4, 2023
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)Chad G Rusthoven, Alyse W Staley, Dexiang Gao, et al.
JAMA Oncology|June 5, 2020
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort StudyChad G Rusthoven, Masaaki Yamamoto, Denise Bernhardt, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cancer|January 25, 2022
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter studyEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Neurosurgery|October 18, 2022
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 PatientsEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Journal of Neurosurgery|September 17, 2022
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patientsEric J Lehrer, Manmeet S Ahluwalia, Jason Gurewitz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2023
Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain MetastasesEric J Lehrer, Roman O Kowalchuk, Jason Gurewitz, et al.
Journal of Neuro-Oncology|October 27, 2023
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patientsEric J Lehrer, Atulya A Khosla, Ahmad Ozair, et al.
Journal of Neurosurgery|October 28, 2022
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma: a multi-institutional studyStylianos Pikis, Georgios Mantziaris, Rithika Kormath Anand, et al.
Acta Neurochirurgica|December 21, 2022
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in patients ≥ 65 years old: a multi-institutional retrospective studyChloe Dumot, Stylianos Pikis, Georgios Mantziaris, et al.
Journal of Neuro-Oncology|September 27, 2022
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional studyChloe Dumot, Stylianos Pikis, Georgios Mantziaris, et al.
Journal of the National Cancer Institute|May 4, 2023
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)Chad G Rusthoven, Alyse W Staley, Dexiang Gao, et al.
JAMA Oncology|June 5, 2020
Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort StudyChad G Rusthoven, Masaaki Yamamoto, Denise Bernhardt, et al.
Pageof 8